Biological Alemtuzumab Clinical Trials Updates During the Last 45 Dayshttp://www.clinicaltrialsfeeds.org/clinical-trials/results/term=Biological+alemtuzumabClinical trials database search returned results for the query Biological alemtuzumab AND ( "12/31/2011" : MAX ) [LAST-RELEASE-DATE].Tue, 14 Feb 2012 10:53:37 GMTComparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Twohttp://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00548405http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00548405Status: Completed, Condition Summary: Multiple Sclerosis, Relapsing-RemittingMon, 30 Jan 2012 05:00:00 GMTAlemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancerhttp://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00118352http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00118352Status: Active, not recruiting, Condition Summary: Acute Undifferentiated Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Atypical Chronic Myeloid Leukemia, BCR-ABL Negative; Burkitt Lymphoma; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Childhood Chronic Myelogenous Leukemia; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Childhood Myelodysplastic Syndromes; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Intraocular Lymphoma; Juvenile Myelomonocytic Leukemia; Mast Cell Leukemia; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Nodal Marginal Zone B-cell Lymphoma; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Recurrent/Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Secondary Myelodysplastic Syndromes; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Waldenstrom MacroglobulinemiaMon, 30 Jan 2012 05:00:00 GMTAn Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumabhttp://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00930553http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00930553Status: Active, not recruiting, Condition Summary: Multiple Sclerosis, Relapsing-RemittingFri, 20 Jan 2012 05:00:00 GMTRituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemiahttp://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01013961http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01013961Status: Recruiting, Condition Summary: LeukemiaFri, 10 Feb 2012 05:00:00 GMTAlemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed By a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disordershttp://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00553098http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00553098Status: Recruiting, Condition Summary: Precancerous ConditionMon, 23 Jan 2012 05:00:00 GMTPhase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathieshttp://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01419704http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01419704Status: Active, not recruiting, Condition Summary: Anemia, Sickle Cell; ThalassemiaFri, 20 Jan 2012 05:00:00 GMTCD3/CD28 Bead Activated T-Cells Following Chemo-Immunotherapy in Patients With Chronic Lymphocytic Leukemiahttp://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01013441http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01013441Status: Active, not recruiting, Condition Summary: Chronic Lymphocytic LeukemiaTue, 10 Jan 2012 05:00:00 GMT